-
861por Ikawa, Hiroaki, Sasahara, Go, Takagi, Ryo, Koto, Masashi, Hasegawa, Azusa, Tsuji, Hiroshi, Kamada, Tadashi“…For this study, we employed the criteria for adverse events presented in Common Terminology Criteria for Adverse Events (CTCAE) v4.0 released by the U.S. National Cancer Institute. Results: Sixty-seven patients were enrolled in this study (Table 1). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
862“…Two comorbidity indices were constructed: the National Cancer Institute index, using 12 months of claims before cancer, and a second index for previously undetected conditions, using three months after cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
863por Kong, Fang-fang, Ying, Hongmei, Du, Cheng-run, Huang, Shuang, Zhou, Jun-jun, Hu, Chao-su“…Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
864por Atla, Pradeep R., Sheikh, Muhammad Y., Mascarenhas, Ranjan, Choudhury, Jayanta, Mills, Paul“…METHODS: A retrospective review of the data from medical records of patients diagnosed with HCC were analyzed at an urban tertiary referral teaching hospital and compared to patients in the California Cancer Registry (CCR) – a participant in the Survival Epidemiology and End Results (SEER)program of the National Cancer Institute (NCI). The main outcome measure was overall survival rates. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
865por Hamza, Adel, Wagner, Jonathan M., Evans, Timothy J., Frasinyuk, Mykhaylo S., Kwiatkowski, Stefan, Zhan, Chang-Guo, Watt, David S., Korotkov, Konstantin V.“…Screening of ∼485 000 ligands from databases at the Genomics Research Institute (GRI) at the University of Cincinnati and the National Cancer Institute (NCI) using our VS approach, which integrated a pharmacophore model and consensus molecular shape patterns of active ligands (4D fingerprints), identified 81 putative inhibitors, and in vitro testing subsequently confirmed two of them as active inhibitors. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
866por Cogdell, David, Chung, Woonbok, Liu, Yuexin, McDonald, J. Matthew, Aldape, Kenneth, Issa, Jean-Pierre J., Fuller, Gregory N., Zhang, Wei“…Analysis of the National Cancer Institute's REMBRANDT dataset, which contains 343 glioma samples, indicated that low AJAP1 gene expression was associated with decreased survival. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
867“…The usual nutrient intake was estimated using the National Cancer Institute method, and compared to nutritional goals to estimate prevalence of inadequate intake. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
868por Lazzeroni, Matteo, Serrano, Davide, Dunn, Barbara K, Heckman-Stoddard, Brandy M, Lee, Oukseub, Khan, Seema, Decensi, Andrea“…Tamoxifen's approval for breast cancer risk reduction dates back to 1998, after results from the Breast Cancer Prevention Trial, co-sponsored by the National Cancer Institute and the National Surgical Adjuvant Breast and Bowel Project, showed a 49% reduction in the incidence of invasive, ER-positive breast cancer in high-risk women. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
869por Fuchs, Michael A., Sato, Kaori, Niedzwiecki, Donna, Ye, Xing, Saltz, Leonard B., Mayer, Robert J., Mowat, Rex B., Whittom, Renaud, Hantel, Alexander, Benson, Al, Atienza, Daniel, Messino, Michael, Kindler, Hedy, Venook, Alan, Ogino, Shuji, Wu, Kana, Willett, Walter C., Giovannucci, Edward L., Meyerhardt, Jeffrey A.“…METHODS: We assessed the association between sugar-sweetened beverage consumption on cancer recurrence and mortality in 1,011 stage III colon cancer patients who completed food frequency questionnaires as part of a U.S. National Cancer Institute-sponsored adjuvant chemotherapy trial. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
870por Sukkurwala, Abdul Qader, Adjemian, Sandy, Senovilla, Laura, Michaud, Mickaël, Spaggiari, Sabrina, Vacchelli, Erika, Baracco, Elisa Elena, Galluzzi, Lorenzo, Zitvogel, Laurence, Kepp, Oliver, Kroemer, Guido“…By means of genetically engineered human osteosarcoma U2OS cells, we screened the 879 anticancer compounds of the National Cancer Institute (NCI) Mechanistic Diversity Set for their ability to promote all these hallmarks of ICD in vitro. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
871por Schmitt, Carol L, Lee, Youn Ok, Curry, Laurel E, Farrelly, Matthew C, Rogers, Todd“…OBJECTIVE: To identify unmet research needs of state and community tobacco control practitioners pertaining to electronic nicotine delivery systems (ENDS or e-cigarettes) that would inform policy and practice efforts at the state and community levels, and to describe ENDS-related research and dissemination activities of the National Cancer Institute-funded State and Community Tobacco Control Research Initiative. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
872por Colaiácovo, Rogério, Assef, Maurício Saab, Ganc, Ricardo Leite, Carbonari, Augusto Pincke Cruz, Silva, Flávio Amaro Oliveira Bitar, Bin, Fang Chia, Rossini, Lúcio Giovanni Baptista“…BACKGROUND AND OBJECTIVES: The National Cancer Institute estimated 40,340 new cases of rectal cancer in the United States in 2013. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
873por Liu, Zhe, Romero-Canelón, Isolda, Habtemariam, Abraha, Clarkson, Guy J., Sadler, Peter J.“…Complex 5 displayed the highest anticancer activity, exhibiting submicromolar potency toward a range of cancer cell lines in the National Cancer Institute NCI-60 screen, ca. 5 times more potent than the clinical platinum(II) drug cisplatin. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
874por Brito, Cláudia, Portela, Margareth Crisóstomo, de Vasconcellos, Mauricio Teixeira Leite“…A cohort of 5,861 women with breast cancer registered in different datasets of the Brazilian National Cancer Institute and the Brazilian Unified Health System were analyzed. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
875por Hamza, Adel, Wagner, Jonathan M., Wei, Ning-Ning, Kwiatkowski, Stefan, Zhan, Chang-Guo, Watt, David S., Korotkov, Konstantin V.“…Subsequently, we applied our combined 4D fingerprint and HWK scoring function VS approach in scaffold-hopping and drug repurposing using the National Cancer Institute (NCI) and Food and Drug Administration (FDA) databases, and we identified new inhibitors with different scaffolds of MycP(1) protease from the mycobacterial ESX-1 secretion system. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
876por Veach, Emma, Xique, Ismael, Johnson, Jada, Lyle, Jessica, Almodovar, Israel, Sellers, Kimberly F., Moore, Calandra T., Jackson, Monica C.“…This research linked CRC mortality data obtained from the National Cancer Institute with data from the United States Census Bureau, the Centers for Disease Control and Prevention, and the National Solar Radiation Database to examine geographic and racial/ethnic differences, and develop a spatial regression model that adjusted for several factors that may attribute to health disparities among ethnic/racial groups. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
877por Drwal, Malgorzata N., Marinello, Jessica, Manzo, Stefano G., Wakelin, Laurence P. G., Capranico, Giovanni, Griffith, Renate“…The study combines ligand- and structure-based drug design methods including pharmacophore models, homology modelling, docking, and virtual screening of the National Cancer Institute compound database. From the 8 compounds identified from the computational work, 6 were tested for their capacity to poison topoisomerase II in vitro: 4 showed selective inhibitory activity for the α- over the β-isoform and 3 of these exhibited cytotoxic activity. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
878por Cesmebasi, Alper, Gabriel, Abigail, Niku, Daniel, Bukala, Karolina, Donnelly, Joseph, Fields, Paul J., Tubbs, R. Shane, Loukas, Marios“…The tumor categories were based on those defined by the US Department of Health and Human Services National Cancer Institute (NCI). Proportional comparisons were applied to evaluate the intra-demographic incidence rate differences. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
879por Fu, Ying, Soni, Rina, Romero, María J, Pizarro, Ana M, Salassa, Luca, Clarkson, Guy J, Hearn, Jessica M, Habtemariam, Abraha, Wills, Martin, Sadler, Peter J“…The two iodido complexes were evaluated in the National Cancer Institute 60-cell-line screen, by using the COMPARE algorithm. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
880por Sanchez, Janeth I., Palacios, Rebecca, Thompson, Beti, Martinez, Vanessa, O’Connell, Mary A.“…A subset of these individuals completed an online CRC risk assessment survey managed by the National Cancer Institute (NCI). Data analysis tested for significant differences in knowledge, physician-patient CRC interactions, CRC risk level perception, and screening rates across diverse ethnic and age groups. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto